| ACURX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US00510M2035 / A41DXH |
| 3ZO0 (Frankfurt) / ACXP (NASDAQ) |
| FRA:3ZO0, ETR:3ZO0, 3ZO0:GR, NASDAQ:ACXP |
| - |
| https://www.acurxpharma.c.. |
|
Acurx Pharmaceuticals, Inc. is a late-stage biopha..
>Volltext.. |
| 7.23 Mio. EUR |
| 2.2 Mio. EUR |
| - |
| -7.86 Mio. EUR |
| -7.81 Mio. EUR |
| -7.26 EUR |
| - |
| 5.03 Mio. EUR |
| -6.69 Mio. EUR |
| 2.39 |
| - |
| 44.21% |
| - |
| - |
| - |
| - |
| ACURX |
| 16.12.25 |
|